Biolife Solutions (BLFS) Cash from Investing Activities (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Cash from Investing Activities data on file, last reported at -$1.8 million in Q1 2026.

• On a quarterly basis, Cash from Investing Activities rose 93.27% year-over-year to -$1.8 million in Q1 2026; TTM through Mar 2026 was -$46.2 million, a 247.37% decrease from a year earlier, with the FY2025 full-year figure at -$71.5 million, down 222.71% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$1.8 million, down from $1.1 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for BLFS reached as high as $73.6 million in Q4 2024 and fell as low as -$39.5 million in Q2 2025.
• Historically, Cash from Investing Activities has averaged -$3.3 million across 5 years, with a median of -$1.8 million in 2026.
• Across the five-year window, Cash from Investing Activities jumped 1760.93% in 2024 and tumbled 12196.83% in 2025, its largest moves.
• Year by year, Cash from Investing Activities stood at -$14.9 million in 2022, then surged by 126.57% to $4.0 million in 2023, then soared by 1760.93% to $73.6 million in 2024, then tumbled by 98.46% to $1.1 million in 2025, then sank by 260.95% to -$1.8 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$1.8 million in Q1 2026, $1.1 million in Q4 2025, and -$6.0 million in Q3 2025.